Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

Global Health

₹1328.7 10.4 | 0.8%

Market Cap ₹35677 Cr.

Stock P/E 74.6

P/B 12.3

Current Price ₹1328.7

Book Value ₹ 108.2

Face Value 2

52W High ₹1513.8

Dividend Yield 0%

52W Low ₹ 615

Global Health Research see more...

Overview Inc. Year: 2004Industry: Hospital & Healthcare Services

Global Health Ltd is a healthcare technology company headquartered in Australia. The company provides software solutions to healthcare providers, hospitals, and government agencies to streamline and improve the delivery of healthcare services. Their flagship product, ReferralNet, is an electronic messaging platform that enables secure communication and sharing of patient information between healthcare professionals. The company's other products include a clinical and practice management software called MasterCare+, and a patient engagement platform called HotHealth. Global Health Ltd's solutions are used by healthcare providers in Australia, New Zealand, and Asia. The company is committed to using technology to improve healthcare outcomes and patient experiences.

Read More..

Global Health Share Price

New

| |

Volume
Price

Quarterly Price

Show Value Show %

Global Health Quarterly Results

#(Fig in Cr.) Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Net Sales 583 521 617 679 694 707 773 844 833 809
Other Income 10 12 9 16 12 25 21 21 22 27
Total Income 593 533 627 695 706 732 794 865 855 836
Total Expenditure 448 441 485 522 534 540 595 631 621 629
Operating Profit 146 92 142 172 172 192 199 234 234 207
Interest 18 28 19 18 21 20 18 20 18 18
Depreciation 33 35 36 37 39 38 40 43 44 45
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 95 29 87 117 112 133 141 171 172 143
Provision for Tax 25 12 28 31 32 32 39 45 49 16
Profit After Tax 70 18 59 86 81 101 102 125 124 127
Adjustments 0 -0 0 0 0 0 0 0 0 0
Profit After Adjustments 70 18 59 86 81 101 102 125 124 127
Adjusted Earnings Per Share 2.8 0.7 2.3 3.4 3 3.8 3.8 4.7 4.6 4.7

Global Health Profit & Loss

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
Net Sales 1194 1382 1277 1343 1441 1500 1447 2167 2694 3259
Other Income 36 45 67 49 65 44 31 39 65 91
Total Income 1230 1427 1344 1392 1506 1544 1478 2206 2759 3350
Total Expenditure 932 1081 1155 1218 1299 1309 1250 1709 2074 2476
Operating Profit 299 347 189 174 207 235 228 497 686 874
Interest 9 14 23 28 21 57 73 86 86 74
Depreciation 64 70 81 86 91 115 123 130 150 172
Exceptional Income / Expenses 0 0 -0 0 0 0 0 0 0 0
Profit Before Tax 226 262 85 60 95 64 32 281 449 627
Provision for Tax 79 92 35 27 34 28 4 84 123 149
Profit After Tax 147 170 51 33 61 36 29 196 326 478
Adjustments 1 0 0 -0 -0 0 0 0 0 0
Profit After Adjustments 147 170 51 33 61 36 29 196 326 478
Adjusted Earnings Per Share 6.2 7.1 2.1 1.4 2.5 1.5 1.2 7.7 12.2 17.8

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 24% 22% 15% 0%
Operating Profit CAGR 38% 43% 32% 0%
PAT CAGR 66% 108% 58% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 101% NA% NA% NA%
ROE Average 16% 11% 8% 9%
ROCE Average 19% 13% 11% 13%

Global Health Balance Sheet

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Shareholder's Funds 879 1057 1139 1217 1305 1350 1382 1616 2428
Minority's Interest 1 0 0 0 0 0 0 0 0
Borrowings 40 113 132 336 589 606 578 768 737
Other Non-Current Liabilities 78 76 109 97 87 403 722 819 954
Total Current Liabilities 214 238 272 334 279 358 405 419 573
Total Liabilities 1212 1485 1653 1984 2259 2716 3087 3622 4692
Fixed Assets 752 914 972 1089 1030 1703 1616 1776 2050
Other Non-Current Assets 50 62 53 423 739 534 969 1034 1062
Total Current Assets 410 509 627 472 490 479 502 812 1579
Total Assets 1212 1485 1653 1984 2259 2716 3087 3622 4692

Global Health Cash Flow

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Opening Cash & Cash Equivalents 63 62 42 44 47 60 148 69 119
Cash Flow from Operating Activities 213 228 115 63 150 175 242 311 645
Cash Flow from Investing Activities -126 -241 -107 -69 -243 -87 -239 -421 -342
Cash Flow from Financing Activities -87 -7 -6 9 113 -1 -81 160 346
Net Cash Inflow / Outflow -0 -20 2 3 19 87 -78 50 648
Closing Cash & Cash Equivalent 62 43 44 47 66 148 69 119 767

Global Health Ratios

# Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Earnings Per Share (Rs) 6.18 7.06 2.09 1.36 2.48 1.47 1.16 7.75 12.16
CEPS(Rs) 8.82 9.98 5.41 4.92 6.18 6.14 6.13 12.87 17.75
DPS(Rs) 0 0 0 0 0 0 0 0 0
Book NAV/Share(Rs) 35.31 41.99 43.89 45.79 49.62 51.42 53.14 63.6 90.35
Core EBITDA Margin(%) 21.99 21.81 9.57 9.33 9.87 12.77 13.61 21.14 23.03
EBIT Margin(%) 19.67 20 8.48 6.55 8.07 8.03 7.27 16.93 19.88
Pre Tax Margin(%) 18.92 18.97 6.68 4.44 6.61 4.26 2.24 12.95 16.68
PAT Margin (%) 12.28 12.32 3.96 2.45 4.23 2.42 1.99 9.05 12.1
Cash Profit Margin (%) 17.61 17.41 10.28 8.88 10.53 10.09 10.51 15.04 17.67
ROA(%) 12.1 12.62 3.23 1.81 2.88 1.46 0.99 5.85 7.84
ROE(%) 17.43 18.36 4.87 3.03 5.24 2.92 2.23 13.4 16.17
ROCE(%) 25.32 26.12 8.63 5.94 6.55 6.2 5.26 16.38 18.71
Receivable days 16.24 16.98 26.04 35.14 40.02 38.11 35.67 26.43 25.36
Inventory Days 7.73 7 7.02 6 5.83 7.52 9.87 7.84 7.71
Payable days 94.1 87.91 125.84 122.57 130.66 147.14 139.29 91.04 97.6
PER(x) 0 0 0 0 0 0 0 0 43.27
Price/Book(x) 0 0 0 0 0 0 0 0 5.82
Dividend Yield(%) 0 0 0 0 0 0 0 0 0
EV/Net Sales(x) -0.15 -0.12 -0.16 0.18 0.3 0.3 0.3 0.17 5.08
EV/Core EBITDA(x) -0.59 -0.47 -1.09 1.4 2.05 1.93 1.92 0.76 19.95
Net Sales Growth(%) 0 15.72 -7.59 5.17 7.29 4.11 -3.58 49.81 24.31
EBIT Growth(%) 0 17.7 -60.81 -18.78 32.26 3.49 -12.72 249.06 45.99
PAT Growth(%) 0 16.06 -70.26 -34.92 85.19 -40.45 -20.7 581.08 66.2
EPS Growth(%) 0 14.34 -70.43 -35.06 83.09 -40.68 -21.09 566.84 56.92
Debt/Equity(x) 0.06 0.13 0.17 0.37 0.49 0.48 0.48 0.52 0.35
Current Ratio(x) 1.92 2.14 2.31 1.41 1.76 1.34 1.24 1.94 2.76
Quick Ratio(x) 1.8 2.02 2.23 1.34 1.68 1.23 1.14 1.81 2.65
Interest Cover(x) 26.34 19.34 4.71 3.11 5.5 2.13 1.45 4.25 6.2
Total Debt/Mcap(x) 0 0 0 0 0 0 0 0 0.06

Global Health Shareholding Pattern

# Sep 2017 Aug 2018 Mar 2019 Mar 2020 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Promoter 55.45 49.27 48.63 48.42 33.08 33.08 33.07 33.06 33.05 33.04
FII 0 0 0 0 9.35 9.89 10.58 10.69 11.36 12.09
DII 0 0 0 0 12.55 12.35 10.8 10.93 11.15 10.25
Public 44.55 50.73 51.37 51.58 45.02 44.68 45.55 45.33 44.44 44.61
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Company has delivered good profit growth of 58% CAGR over last 5 years
  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • Promoter holding is low: 33.04%.
  • Company has a low return on equity of 11% over the last 3 years.
  • Debtor days have increased from 91.04 to 97.6days.
  • Stock is trading at 12.3 times its book value.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Global Health News

Top Unlisted Companies & InstaBuy Companies

Sell or Purchase Share (Tentative Price)

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....